Skip header and navigation

Narrow By

40 records – page 1 of 2.

Acamprosate for alcohol dependence

https://libcat.nshealth.ca/en/permalink/chpams37562
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2268
Available Online
View Pamphlet
Acamprosate is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol completely, not just drink it less. This pamphlet explains how to take this medication, how well acamprosate works, whether acamprosate interacts with any other medications, what will happen if you drink alcohol while taking acamprosate, and how long you will need to take this medication. Possible side effects are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Acamprosate
Alcohol-Related Disorders - therapy
Alcoholism - drug therapy
Subjects (LCSH)
Acamprosate
Alcoholism--Treatment
Specialty
Medications
Abstract
Acamprosate is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol completely, not just drink it less. This pamphlet explains how to take this medication, how well acamprosate works, whether acamprosate interacts with any other medications, what will happen if you drink alcohol while taking acamprosate, and how long you will need to take this medication. Possible side effects are included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2268
Less detail
Nova Scotia Health Authority. Central Zone. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
0613
Available Online
View Pamphlet
This pamphlet will inform the reader about ACE inhibitors and how to use them. The pamphlet explains what this type of medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Angiotensin-Converting Enzyme Inhibitors
Subjects (LCSH)
Angiotensin converting enzyme--Inhibitors
Specialty
Medications
Abstract
This pamphlet will inform the reader about ACE inhibitors and how to use them. The pamphlet explains what this type of medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0613
Less detail

Adalimumab (Humira) therapy

https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Central Zone. Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1207
Available Online
View Pamphlet
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with adalimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1207
Less detail

After sedation and your child

https://libcat.nshealth.ca/en/permalink/chpams35272
Nova Scotia Health Authority. Emergency Department, Hants Community Hospital. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1389
Available Online
View Pamphlet
This pamphlet provides details on how to care for your child after they have received sedation at the Hants Community Hospital. Specific instructions are given for how to keep your child safe and when they may start eating again after sedation.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Emergency Department, Hants Community Hospital
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Child
Conscious Sedation
Subjects (LCSH)
Drugs
Children
Conscious sedation
Specialty
Hants Community Hospital
Medications
Abstract
This pamphlet provides details on how to care for your child after they have received sedation at the Hants Community Hospital. Specific instructions are given for how to keep your child safe and when they may start eating again after sedation.
Responsibility
Prepared by: Emergency Department, Hants Community Hospital
Pamphlet Number
1389
Less detail

Aripiprazole (Abilify, Abilify Maintena)

https://libcat.nshealth.ca/en/permalink/chpams35626
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1627
Available Online
View Pamphlet
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Aripiprazole
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1627
Less detail
Nova Scotia Health Authority. Central Zone. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
0071
Available Online
View Pamphlet
This pamphlet will inform the reader about aspirin and how to use it. The pamphlet explains what this medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aspirin
Subjects (LCSH)
Aspirin
Specialty
Medications
Abstract
This pamphlet will inform the reader about aspirin and how to use it. The pamphlet explains what this medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0071
Less detail

Azathioprine and Mercaptopurine Therapy

https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1079
Available Online
View Pamphlet
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.): digital, PDF file
Subjects (MeSH)
Immunosuppressive Agents
Azathioprine
Mercaptopurine
Subjects (LCSH)
Immunosuppressive agents
Specialty
Medications
Abstract
This pamphlet will help you decide if azathioprine (Imuran®) or mercaptopurine therapy is right for you. The pamphlet explains what azathioprine (AZA) and mercaptopurine (6-MP) are, how well they work, as well as serious and less serious side-effects. The pamphlet also includes a list of what you can do to lower the chances of side-effects.
Notes
Previous title: Azathioprine (Imuran) therapy
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1079
Less detail

Benzodiazepines for alcohol withdrawal

https://libcat.nshealth.ca/en/permalink/chpams37554
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2262
Available Online
View Pamphlet
Benzodiazepines are a group of medications that work as sedatives. They are commonly called “benzos”. Diazepam and lorazepam are 2 benzodiazepines used to manage all stages of alcohol withdrawal. This pamphlet explains how to take this medication, how benzodiazepines help, how your prescriber will decide which benzodiazepine is right for you, how much medication you will need, and possible side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Benzodiazepines
Alcohol-Related Disorders - therapy
Alcoholism - drug therapy
Subjects (LCSH)
Benzodiazepines
Alcoholism--Treatment
Specialty
Medications
Abstract
Benzodiazepines are a group of medications that work as sedatives. They are commonly called “benzos”. Diazepam and lorazepam are 2 benzodiazepines used to manage all stages of alcohol withdrawal. This pamphlet explains how to take this medication, how benzodiazepines help, how your prescriber will decide which benzodiazepine is right for you, how much medication you will need, and possible side effects.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2262
Less detail
Nova Scotia Health Authority. Central Zone. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
0294
Available Online
View Pamphlet
This pamphlet will inform the reader about beta blockers and how to use them. The pamphlet explains what this type of medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Adrenergic beta-Antagonists
Subjects (LCSH)
Adrenergic beta blockers
Specialty
Medications
Abstract
This pamphlet will inform the reader about beta blockers and how to use them. The pamphlet explains what this type of medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0294
Less detail

Bowel preparation for chronic kidney disease before colonoscopy

https://libcat.nshealth.ca/en/permalink/chpams35387
Nova Scotia Health Authority. Renal Program, Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2020.
Pamphlet Number
1475
Available Online
View Pamphlet
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2020
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Cathartics
Colonoscopy
Renal Insufficiency, Chronic
Subjects (LCSH)
Laxatives
Colonoscopy
Chronic renal failure
Specialty
Medications
Nephrology
Abstract
This pamphlet describes how to get ready for a colonoscopy if you have chronic kidney disease. Steps to prepare solutions on the day before your colonoscopy are listed. The day before your procedure and on the day of the test you should drink only clear liquids, and a suggested list is included. Remember not to eat any food or drink milk, or other liquids that are not clear, on the day before your colonoscopy or on the day of the test.
Responsibility
Prepared by: NSHA Renal Program Educators and Pharmacists
Pamphlet Number
1475
Less detail

Buprenorphine for opioid use disorder

https://libcat.nshealth.ca/en/permalink/chpams37561
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2267
Available Online
View Pamphlet
Buprenorphine is a medication used to treat opioid use disorder. This pamphlet explains how to take this medication, how well buprenorphine works, how your health care team will find the right dose for you, how long you will need to take buprenorphine, whether buprenorphine interacts with any other medications, and what happens if you miss doses. Possible side effects are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Buprenorphine
Opioid-Related Disorders - therapy
Subjects (LCSH)
Buprenorphine
Opioid abuse
Specialty
Medications
Abstract
Buprenorphine is a medication used to treat opioid use disorder. This pamphlet explains how to take this medication, how well buprenorphine works, how your health care team will find the right dose for you, how long you will need to take buprenorphine, whether buprenorphine interacts with any other medications, and what happens if you miss doses. Possible side effects are included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2267
Less detail

Cefazolin for peritonitis in peritoneal dialysis

https://libcat.nshealth.ca/en/permalink/chpams35860
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1818
Available Online
View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as cefazolin. This pamphlet explains some of the possible side effects of cefazolin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Cefazolin for peritonitis in PD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Medications
Peritonitis
Peritoneal Dialysis
Subjects (LCSH)
Drugs
Peritonitis
Peritoneal dialysis
Specialty
Nephrology
Medications
Abstract
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as cefazolin. This pamphlet explains some of the possible side effects of cefazolin, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1818
Less detail

Ceftazidime for peritonitis in peritoneal dialysis

https://libcat.nshealth.ca/en/permalink/chpams35861
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1819
Available Online
View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as ceftazidime. This pamphlet explains some of the possible side effects of ceftazidime, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Ceftazidime for peritonitis in PD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Medications
Peritonitis
Peritoneal Dialysis
Subjects (LCSH)
Drugs
Peritonitis
Peritoneal dialysis
Specialty
Nephrology
Medications
Abstract
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as ceftazidime. This pamphlet explains some of the possible side effects of ceftazidime, how to give yourself this drug, and how to store this drug. What to do if you have questions and a list of things to remember are also provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1819
Less detail
Nova Scotia Health Authority. Central Zone. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
0249
Available Online
View Pamphlet
This pamphlet will inform the reader about clopidogrel and how to use it. The pamphlet explains what this medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Anticoagulants
Subjects (LCSH)
Anticoagulants (Medicine)
Specialty
Medications
Abstract
This pamphlet will inform the reader about clopidogrel and how to use it. The pamphlet explains what this medication is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medicines and foods to avoid. Symptoms that would need to be evaluated by a physician in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0249
Less detail

Corticosteroid therapy in inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35480
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2021.
Pamphlet Number
1546
Available Online
View Pamphlet
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation (swelling). To ‘inhibit’ means to slow down or cut down on something. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Corticosteroid therapy in IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2021
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Prednisone
Subjects (LCSH)
Inflammatory bowel diseases
Prednisone
Specialty
Gastrointestinal System
Medications
Abstract
Corticosteroids (kor-ti-koh-STER-oids) are strong inhibitors of inflammation (swelling). To ‘inhibit’ means to slow down or cut down on something. This pamphlet explains what corticosteriods do, how they work, when they are used, and how they are given. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Notes
This pamphlet replaced pamphlet 1139, Prednisone Therapy.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1546
Less detail

Cytomegalovirus (CMV)

https://libcat.nshealth.ca/en/permalink/chpams36606
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2019.
Pamphlet Number
1999
Available Online
View Pamphlet
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2019
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([1] p.) : digital, PDF file
Subjects (MeSH)
Cytomegalovirus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Cytomegalovirus infections
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
The cytomegalovirus (CMV) is a common virus found in people of all ages. People who have had a kidney transplant and are taking immunosuppressive medications are at risk. The pamphlet outlines the symptoms, how the virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1999
Less detail

Disulfiram for alcohol dependence

https://libcat.nshealth.ca/en/permalink/chpams37563
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
2269
Available Online
View Pamphlet
Disulfiram is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol completely, not just drink less. This pamphlet explains how to take this medication, what will happen if you drink alcohol while taking disulfiram, how well disulfiram works, whether disulfiram interacts with other medications or foods, and how long you will need to take this medication. Possible side effects are included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Aberdeen Hospital. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Disulfiram
Alcohol-Related Disorders - therapy
Alcoholism - drug therapy
Subjects (LCSH)
Disulfiram
Alcoholism--Treatment
Specialty
Medications
Abstract
Disulfiram is a medication used to help manage alcohol dependence. It works best for people who would like to stop drinking alcohol completely, not just drink less. This pamphlet explains how to take this medication, what will happen if you drink alcohol while taking disulfiram, how well disulfiram works, whether disulfiram interacts with other medications or foods, and how long you will need to take this medication. Possible side effects are included.
Responsibility
Prepared by: Pharmacy Services, Aberdeen Hospital
Pamphlet Number
2269
Less detail

Gentamicin or tobramycin for peritonitis in peritoneal dialysis

https://libcat.nshealth.ca/en/permalink/chpams35862
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1820
Available Online
View Pamphlet
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as gentamicin or tobramycin. This pamphlet explains some of the possible side effects of gentamicin and tobramycin, how to give yourself these drugs, and how to store these drugs. What to do if you have questions and a list of things to remember are also provided.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Alternate Title
Gentamicin or tobramycin for peritonitis in PD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Medications
Peritonitis
Peritoneal Dialysis
Subjects (LCSH)
Drugs
Peritonitis
Peritoneal dialysis
Specialty
Nephrology
Medications
Abstract
If you have peritonitis (an infection in your peritoneum), your renal team may tell you to take an antibiotic, such as gentamicin or tobramycin. This pamphlet explains some of the possible side effects of gentamicin and tobramycin, how to give yourself these drugs, and how to store these drugs. What to do if you have questions and a list of things to remember are also provided.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1820
Less detail

Golimumab (Simponi) therapy

https://libcat.nshealth.ca/en/permalink/chpams35651
Nova Scotia Health Authority. Central Zone. Division of Gastroenterology. Halifax, NS: Nova Scotia Health Authority , 2016.
Pamphlet Number
1641
Available Online
View Pamphlet
Your healthcare provider feels that treatment with golimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Central Zone. Division of Gastroenterology
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2016
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Golimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your healthcare provider feels that treatment with golimumab may be helpful in managing your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Responsibility
Prepared by: Division of Gastroenterology
Pamphlet Number
1641
Less detail

Heparin to prevent clotting during hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35407
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2017.
Pamphlet Number
1494
Available Online
View Pamphlet
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2017
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Heparin - therapeutic use
Anticoagulants - therapeutic use
Subjects (LCSH)
Heparin
Anticoagulants (Medicine)
Hemodialysis
Specialty
Nephrology
Medications
Abstract
This pamphlet explains how heparin can help a person with kidney disease who is on hemodialysis. This medicine helps people with kidney disease by preventing blood from clotting in the dialysis lines during hemodialysis. How to take the medicine and what side effects to watch for are reviewed.
Responsibility
Prepared by: Renal Program
Pamphlet Number
1494
Less detail

40 records – page 1 of 2.